EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical characteristics and outcomes of acquired hemophilia A before and after emicizumab approval in Japan

Daichi Kishi, Masashi Nishikubo, Yoshimitsu Shimomura, Takayuki Ishikawa, Tadakazu Kondo

Blood Vessels, Thrombosis & Hemostasis · 2024-12 · 1 (4) · 100027

DOI: 10.1016/j.bvth.2024.100027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2024-12. Verfasst von Daichi Kishi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kobe City Medical Center General Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan.
  • Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.

Förderung

  • Kobe City Medical Center General Hospital

Zitieren

APA

Kishi, D., Nishikubo, M., Shimomura, Y., Ishikawa, T., & Kondo, T. (2024). Clinical characteristics and outcomes of acquired hemophilia A before and after emicizumab approval in Japan. Blood Vessels, Thrombosis & Hemostasis, 1(4), 100027. https://doi.org/10.1016/j.bvth.2024.100027

Vancouver

Kishi D, Nishikubo M, Shimomura Y, Ishikawa T, Kondo T. Clinical characteristics and outcomes of acquired hemophilia A before and after emicizumab approval in Japan. Blood Vessels, Thrombosis & Hemostasis. 2024;1(4):100027. doi:10.1016/j.bvth.2024.100027

BibTeX
@article{Kishi2024,
  author = {Kishi, Daichi and Nishikubo, Masashi and Shimomura, Yoshimitsu and Ishikawa, Takayuki and Kondo, Tadakazu},
  title = {Clinical characteristics and outcomes of acquired hemophilia A before and after emicizumab approval in Japan},
  journal = {Blood Vessels, Thrombosis & Hemostasis},
  year = {2024},
  volume = {1},
  number = {4},
  pages = {100027},
  doi = {10.1016/j.bvth.2024.100027}
}
Kostenlos starten →